QUIZ: The ALEX Study for ALK+ Non-Small Cell Lung Cancer

In our lung cancer quiz, you’ll get to test your knowledge on the ALEX study.

What characteristics of alectinib therapy made it a viable treatment option versus crizotinib.

a. It has greater potency/selectivity for ALK.

b. It is a central nervous system penetrant.

c. It has the ability to target resistance mutations.

d. All of the above